Lack of modifying effects of eugenol on development of lung proliferative lesions induced by urethane in transgenic mice carrying the human prototype c-Ha-ras gene.
To investigate the modifying effects of eugenol (EUG), a component of cigarette smoke, on lung carcinogenesis, male and female transgenic mice carrying the human prototype c-Ha-ras gene (rasH2 mice) were given a single intraperitoneal injection of 250 mg/kg urethane (UR) or saline, followed by a diet containing 6,000 ppm EUG or basal diet for 26 weeks. Their non-transgenic CB6F1 littermates (non-Tg mice) were also treated in the same manner. In both male and female rasH2 mice, alveolar/bronchiolar hyperplasias, adenomas and carcinomas were observed in all UR-treated groups. However, there were no significant intergroup differences in the incidences and multiplicities of these lesions between the UR alone and UR + EUG groups. In non-Tg mice, alveolar/bronchiolar hyperplasias, adenomas or carcinomas were sporadically observed in UR-treated groups of both sexes, with no significant differences in the incidences and multiplicities between the UR alone and UR + EUG groups. There were no intergroup differences between them in the PCNA-positive ratios of adenomas or carcinomas and the areas of adenomas or carcinomas to the whole lung area examined. The present results suggest that the EUG treatment does not exert modifying effects on lung carcinogenesis induced by UR in both male and female rasH2 mice and non-Tg mice.
Koujitani
T
T
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.
Yasuhara
K
K
Tamura
T
T
Onodera
H
H
Takagi
H
H
Takizawa
T
T
Hirose
M
M
Hayashi
Y
Y
Mitsumori
K
K
D000236:Adenoma / Q000139:chemically induced* / Q000737:chemistry / Q000473:pathology; D000818:Animals; D001980:Bronchi / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D015197:Carcinogenicity Tests / Q000379:methods; D002273:Carcinogens / Q000633:toxicity*; D002277:Carcinoma / Q000139:chemically induced* / Q000737:chemistry / Q000473:pathology; D003043:Cocarcinogenesis; D004195:Disease Models, Animal; D004357:Drug Synergism; D005054:Eugenol / Q000633:toxicity*; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D011905:Genes, ras; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced / Q000473:pathology; D007124:Immunoenzyme Techniques; D008168:Lung / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000737:chemistry / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D011650:Pulmonary Alveoli / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D014520:Urethane
D002273:Carcinogens; D018809:Proliferating Cell Nuclear Antigen; D014520:Urethane; D005054:Eugenol